China launches a COVID-19 vaccine inhaled through the mouth


PTI, Oct 26, 2022, 2:01 PM IST

Representational Image by iStock

Beijing: The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first.

The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals, according to an announcement posted on an official city social media account.

Needle-free vaccines may persuade people who don’t like getting a shot to get vaccinated, as well as help expand vaccination in poor countries because they are easier to administer.

China doesn’t have vaccine mandates but wants more people to get booster shots before it relaxes strict pandemic restrictions that are holding back the economy and increasingly out of synch with the rest of the world.

A video posted by an online Chinese state media outlet showed people at a community health centre sticking the short nozzle of a translucent white cup into their mouths.

Accompanying text said that after slowly inhaling, one individual held his breath for five seconds, with the entire procedure completed in 20 seconds.

“It was like drinking a cup of milk tea,” one Shanghai resident said in the video. ”When I breathed it in, it tasted a bit sweet.” A vaccine taken in the mouth could also fend off the virus before it reaches the rest of the respiratory system, though that would depend in part on the size of the droplets, one expert said.

Larger droplets would train defenses in parts of the mouth and throat, while smaller ones would travel further into the body, said Dr. Vineeta Bal, an immunologist in India.

Chinese regulators approved the vaccine for use as a booster in September. It was developed by Chinese biopharmaceutical company Cansino Biologics Inc. as an aerosol version of the same company’s one-shot adenovirus vaccine, which uses a relatively harmless cold virus.

Cansino has said the inhaled vaccine has completed clinical trials in China, Hungary, Pakistan, Malaysia, Argentina and Mexico.

Regulators in India have approved a nasal vaccine, another needle-free approach, but it has yet to be rolled out. The vaccine, developed in the US and licensed to Indian vaccine maker Bharat Biotech, is squirted in the nose.

About a dozen nasal vaccines are being tested globally, according to the World Health Organisation.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Assembly clears Mysuru Development Authority Bill

Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam

BJP using legislature for ‘politics’ instead of discussing real issues: CM Siddaramaiah

Congress twisted facts, distorted my statement on Ambedkar: Amit Shah

Govt will not remove temples built on Waqf properties, CM Siddaramaiah tells Assembly

Not God, but Constitution that saves oppressed people: Karnataka Minister Mahadevappa

One dead, 66 rescued after ferry capsizes off Mumbai coast

Related Articles More

Plant-based meat alternatives linked to increased risk of depression in vegetarians, study finds

Lung transplant at right time only cure for idiopathic pulmonary fibrosis that killed Ustad Zakir Hussain

ICMR sets up India’s first diabetes biobank in Chennai

AI Meets Health: The Rise of Smart Fitness Solutions

New study links paracetamol to side effects in digestive tract, heart, kidneys among older adults

MUST WATCH

Feeding Birds with Creative Paddy Art!

Areca Nut

HOTEL SRI DURGA BHAVANA

Harish Poonja

Heartwarming Miracle!


Latest Additions

Assembly clears Mysuru Development Authority Bill

Blocked 18 OTT platforms for publishing obscene, vulgar content: Govt

Boy critically injured after tree branch falls on him in Bengaluru

Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam

Four dead in road accident in Kolar

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.